• Optimizing the Identification of HER2-Low Breast Cancer

  • Jul 30 2024
  • Duración: 24 m
  • Podcast

Optimizing the Identification of HER2-Low Breast Cancer  Por  arte de portada

Optimizing the Identification of HER2-Low Breast Cancer

  • Resumen

  • Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayTestingHER2LowBC24).
    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Optimizing the Identification of HER2-Low Breast Cancer

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.